Related Experiment Video
Updated: Oct 20, 2025

08:48
Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research
Published on: May 24, 2024
2.1K
Intestinal Epithelium Tubules on a Chip
Kinga Kosim1, Iris Schilt1, Henriëtte L Lanz1
1Mimetas BV, Leiden, The Netherlands.
Methods in Molecular Biology (Clifton, N.J.)
|September 14, 2021
Summary
This study introduces a high-throughput microfluidic platform for culturing 3D intestinal tubules. This method enhances in vitro studies of epithelial barrier properties, offering a membrane-free approach for disease modeling and drug transport research.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Physiology
Background:
- Epithelial barrier properties are crucial for disease modeling, drug transport, toxicology, and developmental/regenerative biology.
- Current in vitro methods use static cell cultures on artificial membranes, limiting physiological relevance.
- Advancements in microfluidics and organ-on-a-chip technologies enable more complex in vitro models.
Purpose of the Study:
- To describe protocols for culturing 3D intestinal tubules in a microfluidic, high-throughput format.
- To enable assessment of epithelial tubule permeability and marker expression.
- To facilitate the adoption of microfluidic techniques by non-specialized users.
Main Methods:
- Culture of 3D intestinal tubules directly against extracellular matrix (ECM) under flow using microfluidic chips.
- High-throughput format with 40 independent microfluidic chips in a microtiter plate.
- Parallel analysis of epithelial tubules using high-content microscopy.
Main Results:
- Successful establishment of 3D intestinal tubule cultures in a microfluidic platform.
- Demonstrated capability to assess permeability and marker expression in parallel.
- Developed protocols suitable for routine application by non-specialized researchers.
Conclusions:
- Microfluidic organ-on-a-chip technology provides a membrane-free, physiologically relevant in vitro model for studying epithelial barriers.
- The described high-throughput platform simplifies the application of advanced microfluidic techniques.
- This approach has broad implications for disease modeling, drug development, and regenerative medicine.

